Are We heading toward clarity or confusion?

Chest

Volumn 135, Issue 2, 2009, Pages 252-255

  Dallas, John ^a,b   Kollef, Marin ^a,c  

^a Washington University ^*

^b UNIVERSITY OF WASHINGTON   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; EDITORIAL; ENDOTRACHEAL TUBE; ENTEROBACTERIACEAE; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY; TRACHEOBRONCHITIS; VENTILATOR ASSOCIATED PNEUMONIA; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; INCIDENCE; INTENSIVE CARE UNIT; NOTE; SENSITIVITY AND SPECIFICITY; TRACHEITIS;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; SENSITIVITY AND SPECIFICITY; TRACHEITIS;

EID: 60249087057     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2247     Document Type: Editorial

References (27)

1. Nseir S, Favory R, Jozefowicz E, et al. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized controlled multicenter study. Crit Care 2008; 12:R62
2. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36:2008-2013
3. Craven D, Chroneou A, Zias N, et al. Ventilator-associated tracheobronchitis (VAT): the impact of targeted antibiotic therapy on patient outcomes. Chest 2009; 135:521-528
4. Nseir S, Di Pompeo C, Pronnier P, et al. Nosocomial tracheo-bronchitis in mechanically ventilated patients: incidence, aetiology, and outcome. Eur Respir J 2002; 20:1483-1489
5. Nseir S, Di Pompeo C, Soubrier S, et al. Outcomes of ventilated COPD patients with nosocomial tracheobronchitis: a case-control study. Infection 2004; 32:210-216
6. Bouza E, Perez A, Munoz P, et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 2003; 31:1964-1970
7. Nseir S, Di Pompeo C, Soubrier S, et al. Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study. Critical Care 2005; 9:R238-R245
8. Klompas M. Does this patient have ventilator-associated pneumonia. JAMA 2007; 297:1583-1593
9. Wunderink RG, Woldenberg LS, Zeiss J, et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992; 101:458-463
10. Palmer LB, Smaldone GC, Simon S, et al. Tracheal aspirates in long-term mechanically ventilated patients: a human model of Gram negative infection and inflammation. Chest 1995; 108:1326-1332
11. Baram D, Hulse G, Palmer LB. Stable patients receiving prolonged mechanical ventilation have a higher alveolar burden of bacteria. Chest 2005; 127:1353-1357
12. Rea-Neto A, Youssef NC, Tuche F, et al. Diagnosis of ventilator- associated pneumonia: a systematic review of the literature. Crit Care 2008; 12:R56
13. Talbot GH. What is in the pipeline for Gram-negative pathogens. Expert Rev Anti Infect Ther 2008; 6:39-49
14. Naiemi NA, Heddema ER, Bart A, et al. Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother 2006; 58:853-856
15. Verwaest C, Verhaegen J, Ferdinande P, et al. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 1997; 25:63-71
16. Dennesen PJ, van der Ven AJ, Kessels AG, et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001; 163:1371-1375
17. Sanders KM, Adhikari N, Friedrich JO, et al. Previous cultures are not clinically useful for guiding empiric antibiotics in suspected ventilator-associated pneumonia: secondary analysis from a randomized trial. J Crit Care 2008; 23:58-63
18. Ramirez P, Ferrer M, Torres A. Prevention measures for ventilator-associated pneumonia: a new focus on the endotra-cheal tube. Curr Opin Infect Dis 2007; 20:190-197
19. Saint S, Chenoweth CE. Biofflms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003; 17:411-432
20. Woo AH, Goetz A, Yu VL. Transmission of Legionella by respiratory equipment and aerosol generating devices. Chest 1992; 102:1586-1590
21. Craven DE, Lichtenberg DA, Goularte TA, et al. Contaminated medication nebulizers in mechanical ventilator circuits: source of bacterial aerosols. Am J Med 1984; 77:834-838
22. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endo-tracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008; 300: 805-813
23. Chastre J. Preventing ventilator-associated pneumonia: could silver-coated endotracheal tubes be the answer? JAMA 2008; 300:842-844
24. Rello J, Kollef MH, Diaz E, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endo-tracheal tube in a randomized multi-center feasibility study. Crit Care Med 2006; 34:2766-2772
25. Olson ME, Harmon BG, Kollef MH. Silver-coated endo-tracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest 2002; 121:863-870
26. Hartmann M, Guttmann J, Muller B, et al. Reduction of the bacterial load by the silver-coated endotracheal tube (SCET), a laboratory investigation. Technol Health Care 1999; 7:359-370
27. Kollef MH. SMART approaches for reducing nosocomial infections in the ICU. Chest 2008; 134:447-456